Advanced Search

Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2011 February;146(1) > Giornale Italiano di Dermatologia e Venereologia 2011 February;146(1):69-75

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEGIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014

Frequency: Bi-Monthly

ISSN 0392-0488

Online ISSN 1827-1820

 

Giornale Italiano di Dermatologia e Venereologia 2011 February;146(1):69-75

    REVIEWS

Vitiligo: current medical and scientific understanding

Boissy R. E. 1, Nordlund J. J. 2

1 Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA;
2 Department of Dermatology, Boonshoft School of Medicine, Wright State University Dayton, Ohio and Group Health Associates
Cincinnati, OH, USA

Vitiligo is a relatively common acquired skin depigmentary disease with a complex presentation, therapy, and etiology. Both the prognosis and therapeutic response for patients with vitiligo is unpredictable. Multiple current therapies exist however the efficacy of these are not optimal. The cause of vitiligo appears to be a combination of genetic effects in both the immune system and the melanocyte itself with a precipitating factor instigating their interaction and resulting in the melanocyte destruction. Headway is being made in understanding the etiology of vitiligo that should culminate in new and improved therapies.

language: English


FULL TEXT  REPRINTS

top of page